Company: INSP
Filing Date: 2025-02-10
Form Type: 10-K
Source: 0001609550-25-000011
Chunk: 90

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-02-10
Form: 10-K
Item: Item 8
Chunk 90
---
(205)— (43)— — (43)Issuance of common stock1,587 — 325 — — 325 Sale of common stock from follow-on public offering, net of offering expenses1,150,000 1 243,800 — — 243,801 Issuance of common stock for employee stock purchase plan23,709 — 3,738 — — 3,738 Stock-based compensation expense— — 51,970 — — 51,970 Other comprehensive loss— — — (31)— (31)Net loss— — — — (44,881)(44,881)Balance at December 31, 202229,008,368 29 820,335 (86)(324,270)496,008 Stock options exercised595,188 1 25,808 — — 25,809 Vesting of restricted stock units40,915 — — — — — Shares held for tax withholdings(113,062)— (17,158)— — (17,158)Issuance of common stock1,575 — 353 — — 353 Issuance of common stock for employee stock purchase plan27,480 — 5,299 — — 5,299 Stock-based compensation expense— — 82,470 — — 82,470 Other comprehensive income— — — 886 — 886 Net loss— — — — (21,153)(21,153)Balance at December 31, 202329,560,464 30 917,107 800 (345,423)572,514 Stock options exercised, net376,730 — 21,897 — — 21,897 Vesting of restricted stock units, net57,824 — (4,895)— — (4,895)Issuance of common stock1,716 — 322 — — 322 Issuance of common stock for employee stock purchase plan48,599 — 5,605 — — 5,605 Stock-based compensation expense— — 116,007 — — 116,007 Accelerated share repurchase of common stock(305,